GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Holy Stone Healthcare Co 4194.TWO · TWD

N/A · Taipei Exchange · 🇹🇼 Taiwan

Compare

6.11

+0.16%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

—

FY2016FY2025

Net income

−TWD 111.3m

FY2016FY2025

Free cash flow

−TWD 116.4m

FY2016FY2025

Shareholders' equity

TWD 182.8m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue—TWD 118.8mTWD 236.9mTWD 270.2mTWD 217.1mTWD 221.6mTWD 204.2mTWD 172.8mTWD 138.6mTWD 132.8m
Gross profit—TWD 32.9mTWD 99.4mTWD 123.3mTWD 101.8mTWD 98.5mTWD 103.0mTWD 99.9mTWD 75.6mTWD 67.9m
Research and developmentTWD 126.1mTWD 174.2mTWD 298.3mTWD 179.4mTWD 187.6mTWD 148.3mTWD 194.7mTWD 176.0mTWD 176.4mTWD 191.5m
Operating income−TWD 145.6m−TWD 189.8m−TWD 288.6m−TWD 149.0m−TWD 175.5m−TWD 128.8m−TWD 187.3m−TWD 170.6m−TWD 185.7m−TWD 214.3m
Net income−TWD 111.3m−TWD 183.5m−TWD 289.4m−TWD 152.9m−TWD 181.3m−TWD 128.8m−TWD 190.6m−TWD 174.5m−TWD 181.2m−TWD 219.9m
Diluted earnings per share-0.76-1.26-1.93-1.24-1.65-1.17-2.26-2.29-2.66-3.36

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 220.5mTWD 353.0mTWD 200.6mTWD 614.7mTWD 342.7mTWD 522.8mTWD 655.7mTWD 398.8mTWD 324.7mTWD 438.1m
Cash and short-term investments—TWD 266.7mTWD 85.8mTWD 445.2mTWD 193.6mTWD 351.4mTWD 455.9mTWD 266.6mTWD 170.8mTWD 274.0m
Total liabilitiesTWD 37.7mTWD 58.9mTWD 117.2mTWD 91.9mTWD 78.6mTWD 71.5mTWD 99,000TWD 42.3mTWD 116.2mTWD 45.9m
Debt—TWD 14.4mTWD 77.0mTWD 29.1mTWD 28.8mTWD 27.0mTWD 24.5mTWD 5.0mTWD 70.0m—
Shareholders' equityTWD 182.8mTWD 294.1mTWD 83.4mTWD 522.7mTWD 264.1mTWD 451.3mTWD 576.1mTWD 356.5mTWD 208.6mTWD 392.2m
Shares outstanding146m146m150m123m110m110m84m76m68m65m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 109.1m−TWD 142.7m−TWD 277.3m−TWD 145.9m−TWD 137.9m−TWD 100.9m−TWD 198.8m−TWD 155.4m−TWD 168.5m−TWD 206.0m
Capital spending−TWD 7.3m−TWD 2.1m−TWD 3.5m−TWD 2.1m−TWD 4.3m−TWD 913,000−TWD 3.3m−TWD 452,000−TWD 2.8m−TWD 3.1m
Free cash flow−TWD 116.4m−TWD 144.8m−TWD 280.8m−TWD 148.1m−TWD 142.2m−TWD 101.8m−TWD 202.0m−TWD 155.8m−TWD 171.3m−TWD 209.0m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
Revenue—TWD 47.5mTWD 71.3mTWD 151.0mTWD 85.9mTWD 124.7mTWD 145.6mTWD 108.5m
Gross profit−TWD 6.2mTWD 3.6mTWD 23.1mTWD 66.0mTWD 33.4mTWD 52.9mTWD 70.3mTWD 50.9m
Operating income−TWD 74.2m−TWD 100.1m−TWD 89.7m−TWD 152.5m−TWD 136.1m−TWD 85.1m−TWD 61.7m−TWD 85.0m
Net income−TWD 43.5m−TWD 96.1m−TWD 87.4m−TWD 152.5m−TWD 136.9m−TWD 84.7m−TWD 68.2m−TWD 90.7m
Diluted earnings per share-0.30-0.66-0.60-1.01-0.91-0.69-0.55-0.82
Cash from operations−TWD 49.0m−TWD 34.0m−TWD 108.0m−TWD 189.0m−TWD 88.0m−TWD 77.0m—−TWD 68.0m
Capital spending−TWD 7.0m—−TWD 1.0m−TWD 1.0m−TWD 1.0m——−TWD 2.0m
Free cash flow−TWD 56.0m—−TWD 109.0m−TWD 190.0m−TWD 89.0m——−TWD 70.0m
Total assetsTWD 288.9mTWD 353.0mTWD 432.5mTWD 200.6mTWD 505.9mTWD 614.7m—TWD 342.7m
Cash and short-term investmentsTWD 206.5mTWD 266.7mTWD 306.3mTWD 85.8mTWD 354.7mTWD 445.2m—TWD 193.6m
DebtTWD 10.4mTWD 9.4mTWD 7.5mTWD 64.3mTWD 8.5mTWD 5.6m—TWD 10.2m
Shareholders' equityTWD 250.2mTWD 294.1mTWD 388.4mTWD 83.4mTWD 391.2mTWD 522.7m—TWD 264.1m

Financial ratios

Data as of 5 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin—27.7%42.0%45.6%46.9%44.4%50.5%
Operating margin—-153.9%-119.8%-54.0%-80.9%-56.7%-91.5%
Net margin—-154.5%-122.2%-56.6%-83.5%-58.1%-93.4%
Return on equity-60.9%-62.4%-347.1%-29.3%-68.7%-28.5%—
Return on assets-50.5%-52.0%-144.3%-24.9%-52.9%-24.6%—
Free cash flow yield-11.1%-15.3%-28.9%-18.5%-19.3%-14.4%—
Revenue growth—-49.9%-12.3%24.5%-2.0%8.5%—
Earnings growth-39.3%-36.6%89.2%-15.6%40.8%-32.4%—
Current ratio5.29x5.98x1.30x7.15x4.15x8.61x—
Debt to equity—0.02x0.77x0.02x0.04x0.02x0.01x
Equity ratio82.9%83.3%41.6%85.0%77.1%86.3%—
Interest coverage-430.47x-287.02x-405.32x-233.67x-343.69x-257.98x—
R&D as a share of sales—146.6%125.9%66.4%86.4%66.9%95.4%
Buybacks as a share of market value0.0%2.9%-22.1%-11.9%0.0%-30.6%—

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-0.8%2.5%-2.4%
Net income-10.0%-2.9%-4.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-10.1-10.3-9.9-24.6-17.5-21.1-5.2-6.3-6.8-5.5
Price to sales—15.912.113.914.612.24.86.48.99.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1000-to-886.4 reverse split · 16 Sept 2025
  • 1000-to-886.4 reverse split · 25 Jan 2024
  • 1000-to-886.4 reverse split · 18 Jan 2024
  • 1000-to-886.4 reverse split · 4 Jan 2024
  • 1000-to-886.4 reverse split · 14 Dec 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.